Update shared on 18 Dec 2025
Analysts have modestly raised their price target on Indo Count Industries to ₹333.0, reflecting slightly higher discount rate assumptions while keeping long term growth and profitability expectations broadly unchanged.
What's in the News
- Indo Count Industries has scheduled a board meeting for November 11, 2025 to consider and approve its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, and to take up other business matters (Key Developments).
Valuation Changes
- Fair Value: Unchanged at ₹333.0 per share, indicating no revision to the intrinsic value estimate.
- Discount Rate: Risen slightly from 16.22 percent to about 16.32 percent, reflecting a marginally higher perceived risk or cost of capital.
- Revenue Growth: Effectively unchanged at around 10.75 percent, suggesting stable long term top line growth assumptions.
- Net Profit Margin: Essentially flat at about 7.56 percent, indicating no material shift in long term profitability expectations.
- Future P/E: Increased slightly from about 24.01x to 24.08x, pointing to a marginally higher valuation multiple applied to future earnings.
Have other thoughts on Indo Count Industries?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
